158 related articles for article (PubMed ID: 23094815)
21. Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy.
Cohen PR; Nikanjam M; Kato S; Goodman AM; Kurzrock R
Cureus; 2020 Jul; 12(7):e8967. PubMed ID: 32766009
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
23. Isolated microcytic anemia disclosing a unicentric Castleman disease: The interleukin-6/hepcidin pathway?
Vinzio S; Ciarloni L; Schlienger JL; Rohr S; Méchine A; Goichot B
Eur J Intern Med; 2008 Jul; 19(5):367-9. PubMed ID: 18549942
[TBL] [Abstract][Full Text] [Related]
24. [Recurrent cerebral ischemias due to cerebral vasculitis within the framework of incomplete POEMS syndrome with Castleman disease].
Rössler M; Kiessling B; Klotz JM; Langohr HD
Nervenarzt; 2004 Aug; 75(8):790-4. PubMed ID: 15007508
[TBL] [Abstract][Full Text] [Related]
25. The Role of Radiation Therapy in Unicentric Castleman Disease: A Case Report.
Rodriguez C; Rivera Rubi L; Menjivar O; Suazo J
Cureus; 2023 Nov; 15(11):e49687. PubMed ID: 38161935
[TBL] [Abstract][Full Text] [Related]
26. Two case reports of Castleman disease with pulmonary involvement.
Zhang H; Zhang JQ; Zhong XN; Liu GN; Li MH; Bai J; He ZY; Deng JM
Int J Tuberc Lung Dis; 2015 Mar; 19(3):362-5. PubMed ID: 25686148
[TBL] [Abstract][Full Text] [Related]
27. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
Lee FC; Merchant SH
Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
[TBL] [Abstract][Full Text] [Related]
28. Castleman disease: the great mimic.
Bonekamp D; Horton KM; Hruban RH; Fishman EK
Radiographics; 2011 Oct; 31(6):1793-807. PubMed ID: 21997995
[TBL] [Abstract][Full Text] [Related]
29. Unicentric Castleman disease relapsed after rituximab-CHOP chemotherapy or radiation therapy in an adolescent.
Baek HJ; Kook H; Han DK; Shin MG; Kim HS; Hwang TJ
J Pediatr Hematol Oncol; 2012 Jul; 34(5):e206-8. PubMed ID: 22258344
[TBL] [Abstract][Full Text] [Related]
30. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
[TBL] [Abstract][Full Text] [Related]
31. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
Vitolo U; Chiappella A; Franceschetti S; Carella AM; Baldi I; Inghirami G; Spina M; Pavone V; Ladetto M; Liberati AM; Molinari AL; Zinzani P; Salvi F; Fattori PP; Zaccaria A; Dreyling M; Botto B; Castellino A; Congiu A; Gaudiano M; Zanni M; Ciccone G; Gaidano G; Rossi G;
Lancet Oncol; 2014 Jun; 15(7):730-7. PubMed ID: 24831981
[TBL] [Abstract][Full Text] [Related]
32. Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients.
Hill AJ; Tirumani SH; Rosenthal MH; Shinagare AB; Carrasco RD; Munshi NC; Ramaiya NH; Howard SA
Br J Radiol; 2015 May; 88(1049):20140670. PubMed ID: 25710283
[TBL] [Abstract][Full Text] [Related]
33. Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.
Zhou X; Wei J; Lou Y; Xu G; Yang M; Liu H; Mao L; Tong H; Jin J
Front Med; 2017 Jun; 11(2):287-292. PubMed ID: 28367597
[TBL] [Abstract][Full Text] [Related]
34. A rare case of bilateral orbital Castleman disease.
Mukherjee B; Alam MS; Krishnakumar S
Orbit; 2014 Aug; 33(4):314-7. PubMed ID: 24831817
[TBL] [Abstract][Full Text] [Related]
35. Development of a Hodgkin disease tumor in the neck of a patient who previously had undergone complete excision of a hyaline-vascular Castleman disease neck mass.
Unsal Tuna EE; Ozbek C; Arda N; Ilkdogan E; Dere H; Ozdem C
Ear Nose Throat J; 2010 Apr; 89(4):E20-3. PubMed ID: 20397132
[TBL] [Abstract][Full Text] [Related]
36. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
[TBL] [Abstract][Full Text] [Related]
37. IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.
Galeotti C; Tran TA; Franchi-Abella S; Fabre M; Pariente D; Koné-Paut I
J Pediatr Hematol Oncol; 2008 Dec; 30(12):920-4. PubMed ID: 19131781
[TBL] [Abstract][Full Text] [Related]
38. Treatment of unicentric Castleman disease with neoadjuvant rituximab.
Bandera B; Ainsworth C; Shikle J; Rupard E; Roach M
Chest; 2010 Nov; 138(5):1239-41. PubMed ID: 21051400
[TBL] [Abstract][Full Text] [Related]
39. Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion.
Akman AO; Basaran O; Ozyoruk D; Han U; Sayli T; Cakar N
Eur J Pediatr; 2016 Jun; 175(6):873-6. PubMed ID: 26614115
[TBL] [Abstract][Full Text] [Related]
40. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
